Ads
related to: Pfizer
Search results
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
Motley Fool via Yahoo Finance· 17 hours agoPfizer stock lost nearly half its value over the past couple of years, but some of the world's most...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 1 day agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
Pfizer Tax Practices Targeted by Congress in Wider Pharma Probe
Bloomberg Law· 14 hours agoSenate Finance Chair Ron Wyden (D-Ore.) demanded information into the tax practices of Pfizer Inc., expanding his panel’s probe into the profit-shifting practices of US pharmaceutical companies.
The Highest Paid CEOs of 2023
The Wall Street Journal· 24 hours agoBottom of the pack Among the 25 worst-performing companies in the Journal analysis, nearly a third operated in the healthcare sector, including six...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 4 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 6 days agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc....
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 1 day agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer . Looking at options history for Pfizer PFE we ...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 6 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 18 hours agoTwo of these ultra-high-yield S&P 500 dividend stocks are nothing short of screaming buys right now....
This overlooked obesity-drug stock has 80% upside, JPMorgan says
Business Insider via Yahoo Finance· 1 hour agoJPMorgan said early results suggest the drug candidate offers "on par" weight loss results for...